These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31463940)

  • 1. Estimating the seroprevalence of chikungunya virus exposure in Shimoga district, Karnataka state: A hospital-based study during 2014-2018.
    Shilpa C; Kavitha K; Sudheesh N; Sabeena S; Prasad V; Hindol M; Arunkumar G
    J Med Virol; 2020 Jan; 92(1):119-123. PubMed ID: 31463940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study.
    Raghavendhar BS; Ray P; Ratagiri VH; Sharma BS; Kabra SK; Lodha R
    J Med Virol; 2016 Jun; 88(6):923-30. PubMed ID: 26581026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of chikungunya virus infection among febrile patients in northwest Ethiopia.
    Ferede G; Tiruneh M; Abate E; Wondimeneh Y; Gadisa E; Howe R; Aseffa A; Tessema B
    Int J Infect Dis; 2021 Mar; 104():183-188. PubMed ID: 33373719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of Chikungunya virus seroprevalence in Myanmar among dengue-suspected patients and healthy volunteers in 2013, 2015, and 2018.
    Luvai EAC; Kyaw AK; Sabin NS; Yu F; Hmone SW; Thant KZ; Inoue S; Morita K; Ngwe Tun MM
    PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009961. PubMed ID: 34851949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence and clinical manifestations of chikungunya virus infection in rural areas of Chandrapur, Maharashtra, India.
    Kawle AP; Nayak AR; Bhullar SS; Borkar SR; Patankar SD; Daginawala HF; Singh LR; Kashyap RS
    J Vector Borne Dis; 2017; 54(1):35-43. PubMed ID: 28352044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of Chikungunya virus and living conditions in Feira de Santana, Bahia-Brazil.
    Teixeira MG; Skalinski LM; Paixão ES; Costa MDCN; Barreto FR; Campos GS; Sardi SI; Carvalho RH; Natividade M; Itaparica M; Dias JP; Trindade SC; Teixeira BP; Morato V; Santana EB; Goes CB; Silva NSJ; Santos CAST; Rodrigues LC; Whitworth J
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009289. PubMed ID: 33878115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population.
    Ang LW; Kam YW; Lin C; Krishnan PU; Tay J; Ng LC; James L; Lee VJM; Goh KT; Ng LFP; Lin RTP
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006163. PubMed ID: 29281644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of chikungunya virus infection in five hospitals within Anyigba, Kogi State of Nigeria.
    Omatola CA; Onoja BA; Fassan PK; Osaruyi SA; Iyeh M; Samuel MA; Haruna PU
    Braz J Infect Dis; 2020; 24(1):1-6. PubMed ID: 32001210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of Chikungunya Virus in a Rural Community in Brazil.
    Cunha RV; Trinta KS; Montalbano CA; Sucupira MV; de Lima MM; Marques E; Romanholi IH; Croda J
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005319. PubMed ID: 28107342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
    Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
    Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
    Yoon IK; Alera MT; Lago CB; Tac-An IA; Villa D; Fernandez S; Thaisomboonsuk B; Klungthong C; Levy JW; Velasco JM; Roque VG; Salje H; Macareo LR; Hermann LL; Nisalak A; Srikiatkhachorn A
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Seroprevalence Indicates Vulnerability of Eastern and Central Sudan to Infection with Chikungunya Virus.
    Adam A; Seidahmed OM; Weber C; Schnierle B; Schmidt-Chanasit J; Reiche S; Jassoy C
    Vector Borne Zoonotic Dis; 2016 Apr; 16(4):290-1. PubMed ID: 26974266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Anti-Chikungunya Virus Antibodies in Children and Adults in Managua, Nicaragua, After the First Chikungunya Epidemic, 2014-2015.
    Kuan G; Ramirez S; Gresh L; Ojeda S; Melendez M; Sanchez N; Collado D; Garcia N; Mercado JC; Gordon A; Balmaseda A; Harris E
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004773. PubMed ID: 27322692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and Symptomatic Attack Rate of Chikungunya Virus Infection, United States Virgin Islands, 2014-2015.
    Hennessey MJ; Ellis EM; Delorey MJ; Panella AJ; Kosoy OI; Kirking HL; Appiah GD; Qin J; Basile AJ; Feldstein LR; Biggerstaff BJ; Lanciotti RS; Fischer M; Staples JE
    Am J Trop Med Hyg; 2018 Nov; 99(5):1321-1326. PubMed ID: 30226143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Dengue and Chikungunya Virus Antibodies, French Polynesia, 2014-2015.
    Aubry M; Teissier A; Huart M; Merceron S; Vanhomwegen J; Mapotoeke M; Mariteragi-Helle T; Roche C; Vial AL; Teururai S; Sicard S; Paulous S; Desprès P; Manuguerra JC; Mallet HP; Imrie A; Musso D; Deparis X; Cao-Lormeau VM
    Emerg Infect Dis; 2018 Mar; 24(3):558-561. PubMed ID: 29460745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-Dependent Evaluation of Immunoglobulin G Response after Chikungunya Virus Infection.
    Patil HP; Gosavi M; Mishra AC; Arankalle VA
    Am J Trop Med Hyg; 2021 Feb; 104(4):1438-1443. PubMed ID: 33617471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chikungunya Outbreaks in India: A Prospective Study Comparing Neutralization and Sequelae during Two Outbreaks in 2010 and 2016.
    Jain J; Kaur N; Haller SL; Kumar A; Rossi SL; Narayanan V; Kumar D; Gaind R; Weaver SC; Auguste AJ; Sunil S
    Am J Trop Med Hyg; 2020 Apr; 102(4):857-868. PubMed ID: 32067624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible vertical transmission of Chikungunya virus infection detected in the cord blood samples from a birth cohort in Vietnam.
    Ngwe Tun MM; Luvai EAC; Toizumi M; Moriuchi M; Takamatsu Y; Inoue S; Urano T; Bui MX; Thai Hung D; Thi Nguyen HA; Anh DD; Yoshida LM; Moriuchi H; Morita K
    J Infect Public Health; 2024 Jun; 17(6):1050-1056. PubMed ID: 38688178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dengue and chikungunya virus infections in north-eastern Tanzania: a cross sectional study among participants presenting with malaria-like symptoms.
    Kajeguka DC; Kaaya RD; Mwakalinga S; Ndossi R; Ndaro A; Chilongola JO; Mosha FW; Schiøler KL; Kavishe RA; Alifrangis M
    BMC Infect Dis; 2016 Apr; 16():183. PubMed ID: 27112553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective investigation of antibodies against chikungunya virus (CHIKV) in serum from febrile patients in Mozambique, 2009-2015: Implications for its prevention and control.
    Antonio VS; Amade NA; Muianga AF; Ali S; Monteiro V; Mula F; Chelene I; Oludele J; Chongo I; José A; Augusto O; Gudo ES
    PLoS One; 2019; 14(3):e0213941. PubMed ID: 30897135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.